News – Page 1063 – Endpoints News

Genomics meets blockchain: Harvard team featuring George Church launches peer-to-peer genome sequencing startup

8 years ago

No more Mr Nice Guy: GlaxoSmithKline is coming out of its corner swinging

8 years ago

Gilead gets a blockbuster boost from an FDA OK of HIV triplet Biktarvy — and rival GSK fires back

8 years ago

Case Western/Sangamo get $11M grant to wipe out HIV; Sage's depression drug, GSK's vaccine get breakthrough therapy ...

8 years ago

Verastem takes AbbVie’s blood cancer castoff to the FDA

8 years ago

Sanofi sounds taps on a half dozen drug programs in latest pipeline cleanup

8 years ago

Biogen scuttles a Tysabri program after the drug fails stroke test, thinning the pipeline

8 years ago

North of a billion biotech VC dollars to come from C-Bridge, Rothschild as global biopharma capital flows

8 years ago

J&J antes up on a $1B gamble that Theravance has the next blockbuster JAK for Crohn’s, ulcerative colitis

8 years ago

Secret meetings, mergers and a board putsch: Arcturus founder/CEO claims 4 board members conspired on his ouster

8 years ago

Taking on lousy side effects of existing meds, NEA-backed Xoc tackles Parkinson’s/migraines with $30M Series A

8 years ago

Nessan Bermingham returns to VC life; Sanofi's generics unit gets two industry bidders in EMS and Torrent Pharma

8 years ago

Array MEK/BRAF combo beats out Roche rival in PhIII melanoma OS showdown

8 years ago

Eyeing a blockbuster migraine market, Allergan takes an inside track on acute cases with positive PhIII

8 years ago

Zogenix wins inside track at FDA with childhood epilepsy ‘breakthrough’

8 years ago

The Endpoints 100: Biotech execs stampede into 2018 with a cheer for the FDA and bullish feelings on public markets, ...

8 years ago

Looking to grow blockbuster Pomalyst franchise, Celgene declares a win for multiple myeloma triplet in pivotal PhIII

8 years ago

Roche hails another PhIII win on Tecentriq combo, reports promising kidney cancer data

8 years ago

Pfizer vs J&J: Researchers are duking it out for the championship title in nonmetastatic prostate cancer

8 years ago

Bristol-Myers offers some eagerly awaited Checkmate-227 results, but they're not changing medical practice -- yet

8 years ago

Allergan taps Catalent's Matthew Walsh as CFO; ReViral meets endpoints in PhIIa RSV trial

8 years ago

Stock plummets at EyeGate following Phase IIb flop for cataract surgery

8 years ago

As controversy over childhood deaths simmers in the Philippines, Sanofi balks at a Dengvaxia reimbursement

8 years ago

Skeptics pounce after Bristol-Myers scores an early hit on Opdivo-Yervoy combo for lung cancer

8 years ago

First page Previous page 1060 1061 106210631064 1065 1066 Next page Last page